The New England journal of medicine | 16 Oct 2015
D Bassler, R Plavka, ES Shinwell, M Hallman, PH Jarreau, V Carnielli, JN Van den Anker, C Meisner, C Engel, M Schwab, HL Halliday and CF Poets
Systemic glucocorticoids reduce the incidence of bronchopulmonary dysplasia among extremely preterm infants, but they may compromise brain development. The effects of inhaled glucocorticoids on outcomes in these infants are unclear.
* Data courtesy of Altmetric.com